XRN · Chiron Real Estate Inc. · Financials
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Chart any reported metric, KPI or segment over time — the full statement history lives here
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $153.43M | $148.21M | $138.78M | $141.05M | $137.28M | $115.94M | $93.73M | $70.73M | $53.19M | $30.34M | $8.21M | $2.06M | $380.41K | — | — | |
| $150.29M | $147.68M | $138.41M | $140.93M | $137.17M | $115.8M | $93.52M | $70.52M | $53.14M | $30.22M | $8.08M | $2.05M | — | — | — | |
| $20.66M | $20M | $21.12M | $16.85M | $16.55M | $16.45M | $11.94M | $6.54M | $5.54M | $5.49M | $4.22M | $425K | $454.87K | $45.34K | $50.11K | |
| — | — | — | — | — | — | — | — | — | — | — | $659.67K | — | — | — | |
| — | $13.01M | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| $129.85M | — | — | $134.01M | $124.04M | $98.66M | $96.23M | $61.14M | $46.31M | $30.43M | $14.56M | $3.67M | $1.03M | $45.34K | $50.11K | |
| $32.62M | $31.75M | $28.69M | $30.89M | $25.23M | $19.7M | $18.68M | $17.47M | $14.98M | $7.44M | $4.14M | $1.52M | $298.66K | — | — | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | $0 | |
| $62.73M | -$6.88M | $6.69M | $21.73M | $20M | $18.34M | -$2.5M | $9.59M | $14.56M | -$87K | -$6.35M | -$1.61M | -$652.21K | -$45.34K | -$50.11K | |
| — | -4.64% | 4.82% | 15.41% | 14.57% | 15.82% | -2.67% | 13.56% | 27.37% | -0.29% | -77.37% | -78.03% | -171.45% | — | — | |
| $4.78M | -$1.05M | $59K | $1.12M | $854K | $720K | -$574K | $354K | $1.07M | -$49K | $0 | $0 | — | — | — | |
| $49.12M | -$12.12M | $811K | $14.79M | $13.32M | $11.8M | -$7.75M | $3.41M | $7.67M | -$1.75M | -$6.35M | -$1.61M | — | — | — | |
| $72.47M | — | — | — | — | $29.93M | -$14.04M | $6.64M | $10.84M | -$87K | -$6.35M | — | — | — | — | |
| USD/shares | $3.71 | -$0.91 | $0.06 | $1.13 | $1.00 | $0.95 | -$0.85 | $0.50 | — | — | — | — | — | — | — |
| USD/shares | $3.71 | -$0.91 | $0.06 | $1.13 | $1.00 | $0.95 | -$0.85 | $0.50 | — | — | — | — | — | — | — |
| shares | — | 13.38M | 13.19M | 13.11M | 13.09M | 12.13M | 9.25M | 6.77M | 4.39M | 3.92M | 1.86M | 50K | 9671.2 | 1.57M | 1.1M |
| shares | — | 13.38M | 13.19M | 13.11M | 13.09M | 12.13M | 9.25M | 6.77M | 4.39M | 3.92M | 1.86M | 50K | 9671.2 | 1.57M | — |
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2015–FY2025: $6M in buybacks, $47.32M in dividends.
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Line of credit borrowings, including current maturities | 2026-06-30 | USD 632,021,000 | 10-Q filed 2026-08-10 |
| Notes payable, including current maturities | 2026-06-30 | USD 1,096,000 | 10-Q filed 2026-08-10 |
| Operating lease liabilities | 2026-06-30 | USD 13,393,000 | 10-Q filed 2026-08-10 |
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
Peer medians compare against the 8 similar-size REIT - Healthcare Facilities companies (of 17 listed).
P/FFO uses the company-stated “FFO attributable to common stockholders and noncontrolling interest”, extracted from the reconciliation in its SEC filings — the company's own non-GAAP definition, not an XBRL-tagged figure.
Valuation over time computed as of each quarter's filing date
P/FFO and P/AFFO use the company-stated “FFO attributable to common stockholders and noncontrolling interest” and “AFFO attributable to common stockholders and noncontrolling interest”, extracted from the reconciliation in its SEC filings as it existed at each sample date — the company's own non-GAAP definition, not an XBRL-tagged figure. Each point's tooltip names its TTM or fiscal-year basis.